Also, BC cell killing has been achieved at a very low level of E:T ratio such as 0.5:1 even when the CD32-CR T cell transduction has been lower than 100% indicating that the extent of CD32-CR T cell anti-tumor activity is strikingly powerful. The gene discussed is FCGR2C; the disease is neoplasm.